Product How it works Pricing Blog FAQ About Contact
TG Therapeutics

TG Therapeutics (NASDAQ: TGTX) net income

TG Therapeutics reported a net profit of $447.2m for fiscal 2025, 1,812.4% more than in fiscal 2024 ($23.4m). Its net margin was 72.6%. Earnings per share were $3.10.

TG Therapeutics has grown its net income for 2 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. It reported a loss in 7 of those 10 years.

Net income, in millions of US dollars-78.32016-118.52017-173.52018-172.92019-279.42020-348.12021-223.8202212.7202323.42024447.22025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Net income by fiscal year

Fiscal yearNet incomeChangeNet marginEarnings per share
2025$447.2m+1,812.4%72.6%$3.10
2024$23.4m+84.5%7.1%$0.16
2023$12.7m—5.4%$0.09
2022−$223.8m—−8,036.3%−$1.65
2021−$348.1m—−5,204.1%−$2.63
2020−$279.4m—−183,803.3%−$2.42
2019−$172.9m—−113,730.9%—
2018−$173.5m—−114,132.9%—
2017−$118.5m—−77,944.7%—
2016−$78.3m—−51,482.2%—

The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

TG Therapeutics net income compared with its sector

By net income for its latest fiscal year, TG Therapeutics ranks 63rd of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of TG Therapeutics, 72.6%.

RankCompanyNet incomeNet margin
61stMolina Healthcare$472.0m1.0%
62ndMedpace$451.1m17.8%
63rdTG Therapeutics$447.2m72.6%
64thNovavax$440.3m39.2%
65thAlign Technology$410.4m10.2%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the net income of TG Therapeutics

How much did TG Therapeutics earn in fiscal 2025?
TG Therapeutics reported a net profit of $447.2m for fiscal 2025. In fiscal 2024 it reported a net profit of $23.4m.
What are the earnings per share of TG Therapeutics?
They were $3.10 in fiscal 2025, compared with $0.16 in fiscal 2024.
What is the net margin of TG Therapeutics?
In fiscal 2025 its net profit was 72.6% of its revenue.
What was the most profitable year for TG Therapeutics?
Of its last 10 fiscal years, fiscal 2025, with $447.2m.
Where does TG Therapeutics rank in its sector by net income?
It ranks 63rd of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
Where do the figures for TG Therapeutics come from?
From the annual report (Form 10-K) that TG Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that TG Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on TG Therapeutics: the TG Therapeutics page · annual accounts · revenue · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.